Donga ST announced that Marketing Authorization Application of superbacteria-target antibiotics ‘Tedizolid phosphate’ passed preliminary examination

On March 3, Donga ST announced that Marketing Authorization Application of superbacteria-target antibiotics ‘Tedizolid phosphate’ with indication of complicated Skin and Soft Tissue Infections, passed preliminary examination of European Medicines Agency. Donga ST had exported technology of Tedizolid phosphate to Trius Therapeutics( now Cubist) in January 2007.

As the preliminary examination is...